World's Best Scientists 2026 revealed!
John G. McHutchison

John G. McHutchison

D-Index & Metrics

Medicine

D-Index
142
Citations
101537
World Ranking
1535
National Ranking
892

John G. McHutchison publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John G. McHutchison sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 728 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

John G. McHutchison D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John G. McHutchison sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 142 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the Australian Academy of Health and Medical Science
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

John G. McHutchison is affiliated with Duke University in the United States and has a research focus primarily in the field of Medicine. Their work encompasses several subfields including Epidemiology, Hepatology, Hematology, Genetics, and Molecular Biology.

The scientist's research spans main topics such as Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, HIV, Drug Use, Sexual Risk, Liver Disease and Transplantation, Influenza Virus Research Studies, and Blood groups and transfusion.

Recent published papers by John G. McHutchison include:

  • Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study, 2021, The Lancet. Gastroenterology & hepatology
  • Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure, 2021, Nature Communications
  • ASK1/p38 axis inhibition blocks the release of mitochondrial "danger signals" from hepatocytes and suppresses progression to cirrhosis and liver cancer, 2024, Hepatology
  • Quantitation of Pretreatment Serum IP-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response, 2020, UNC Libraries
  • Reduced Hepatitis C Incidence Associated with Rapid Treatment Scale-Up in Australian Prisons: Treatment-as-Prevention in the SToP-C Study, 2020, SSRN Electronic Journal

Frequent co-authors collaborating with John G. McHutchison include:

  • Natasha K. Martin
  • Nezam H. Afdhal
  • Behzad Hajarizadeh
  • Jason Grebely
  • Marianne Byrne

The scientist often publishes work in venues such as UNC Libraries, The Lancet. Gastroenterology & hepatology, Hepatology, Nature Communications, and SSRN Electronic Journal.

John G. McHutchison has been recognized with awards including Fellowship of the Australian Academy of Health and Medical Science in 2018 and membership in the Association of American Physicians.

Best Publications

  • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

    Michael P. Manns;John G. McHutchison;Stuart C. Gordon;Vinod K. Rustgi

  • Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

    John G. Mchutchison;Stuart C. Gordon;Eugene R. Schiff;Mitchell L. Shiffman

  • Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

    Dongliang Ge;Jacques Fellay;Alexander J. Thompson;Jason S. Simon

  • Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie

  • Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

    David L. Thomas;Chloe L Thio;Maureen P. Martin;Ying Qi

  • Sofosbuvir for previously untreated chronic hepatitis C infection

    Eric Lawitz;Alessandra Mangia;David Wyles;Maribel Rodriguez-Torres

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

    John G. McHutchison;Eric J. Lawitz;Mitchell L. Shiffman;Andrew J. Muir

  • Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    Nezam Afdhal;K. Rajender Reddy;David R. Nelson;Eric Lawitz

  • Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

    Thierry Poynard;John McHutchison;Michael Manns;Christian Trepo

  • Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

    Kris V. Kowdley;Stuart C. Gordon;K. Rajender Reddy;Lorenzo Rossaro

  • Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

    Ira M. Jacobson;Stuart C. Gordon;Kris V. Kowdley;Eric M. Yoshida

  • Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

    John G. McHutchison;Gregory T. Everson;Stuart C. Gordon;Ira M. Jacobson

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C

    John G. McHutchison;Michael Manns;Keyur Patel;Thierry Poynard

  • Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

    Gary L. Davis;John B. Wong;John G. McHutchison;Michael P. Manns

  • Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

    Stefan Zeuzem;Geoffrey M. Dusheiko;Riina Salupere;Alessandra Mangia

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C

    Thierry Poynard;Vlad Ratziu;Frédéric Charlotte;Zachary Goodman

Frequent Co-Authors

Andrew J. Muir
Andrew J. Muir Duke University
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
Ira M. Jacobson
Ira M. Jacobson New York University
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Alexander J. Thompson
Alexander J. Thompson Ascension Health
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Hongmei Mo
Hongmei Mo Gilead Sciences (United States)
Hans L. Tillmann
Hans L. Tillmann East Carolina University
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online healthcare degrees can open new career pathways for those interested in medicine, but seeking flexibility. For future healthcare leaders, there are several cahme accredited online healthcare administration programs that deliver rigorous training in administration and policy, preparing graduates for management roles in hospitals and clinics.

If you’re already a registered nurse, enrolling in an rn to bsn online with no clinicals program can help you advance your credentials at your own pace, without the need for traditional clinical placements.

For nurses aiming to reach the highest levels of practice, there are options like the fastest dnp program, designed for rapid completion, as well as flexible dnp programs online that emphasize accessible pathways to advanced practice nursing.

These degree options can help you achieve your career goals while balancing personal and professional commitments, providing alternative routes to serving in the U.S. healthcare system.

Best Scientists Citing John G. McHutchison

Trending Scientists

Recently Published Articles